CAM
PHVS icon

Cormorant Asset Management’s Pharvaris PHVS Stock Holding History

Cormorant Asset Management’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.3M Sell
1,000,000
-83,000
-8% -$2.22M 1.42% 21
2025
Q4 		$30.1M Sell
1,083,000
-280,200
-21% -$6.75M 1.39% 20
2025
Q3 		$34M Sell
1,363,200
-91,460
-6% -$2.03M 2.35% 13
2025
Q2 		$25.6M Sell
1,454,660
-11,800
-0.8% -$190K 1.91% 16
2025
Q1 		$23M Hold
1,466,460
– – 1.73% 16
2024
Q4 		$28.1M Hold
1,466,460
– – 1.54% 18
2024
Q3 		$27.2M Hold
1,466,460
– – 1.44% 23
2024
Q2 		$27.6M Sell
1,466,460
-245,000
-14% -$4.99M 1.59% 23
2024
Q1 		$39.6M Hold
1,711,460
– – 1.74% 16
2023
Q4 		$48M Buy
1,711,460
+350,000
+26% +$7.08M 2.29% 10
2023
Q3 		$28.4M Buy
1,361,460
+387,846
+40% +$7.15M 1.66% 16
2023
Q2 		$14.7M Buy
973,614
+157,154
+19% +$1.52M 0.83% 31
2023
Q1 		$6.58M Hold
816,460
– – 0.43% 44
2022
Q4 		$9.19M Sell
816,460
-391,040
-32% -$2.06M 0.61% 41
2022
Q3 		$9.26M Buy
1,207,500
+61,547
+5% +$962K 0.65% 41
2022
Q2 		$25.3M Buy
1,145,953
+461,065
+67% +$8.59M 1.91% 20
2022
Q1 		$12.4M Sell
684,888
-4,843
-0.7% -$85.4K 0.95% 29
2021
Q4 		$9.93M Hold
689,731
– – 0.59% 43
2021
Q3 		$12.2M Sell
689,731
-55,132
-7% -$944K 0.5% 49
2021
Q2 		$13.6M Sell
744,863
-119,280
-14% -$2.71M 0.46% 51
2021
Q1 		$23.8M Buy
+864,143
New +$27.2M 0.53% 42

Other funds holding PHVS

GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $1.02B AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Cormorant Asset Management's PHVS Position: Q1 2026 in Review

Cormorant Asset Management reduced its Pharvaris (PHVS) stake by 7.7% in Q1 2026, selling an estimated $2.22M and leaving 1,000,000 shares worth $28.3M. The position accounts for 1.42% of the portfolio, ranked #21.

Cormorant Asset Management first reported a position in PHVS in Q1 2021 and has held it in 21 quarters since. The position peaked at $48M in Q4 2023. 110 funds tracked by Wall St. Rank hold PHVS as of Q1 2026.

  • Cormorant Asset Management held 1,000,000 shares of Pharvaris worth $28.3M as of Q1 2026.
  • Cormorant Asset Management sold 83,000 Pharvaris shares in Q1 2026, an estimated $2.22M.
  • Pharvaris made up 1.42% of Cormorant Asset Management's portfolio in Q1 2026, its #21 holding.
  • Cormorant Asset Management first reported a position in Pharvaris in Q1 2021 and has held it in 21 quarters since.
  • Cormorant Asset Management's Pharvaris position peaked at $48M in Q4 2023.
  • 110 funds tracked by Wall St. Rank held Pharvaris as of Q1 2026.

Based on Cormorant Asset Management's 13F filing for Q1 2026, filed 15 May 2026.